This inventor holds 2 USPTO granted patents. Top assignees: Able Corporation, Kobe University. Active years: 2024-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:

Years Active: 2024-2026
Title: Satoshi Tomita: Innovator in Virus Inactivation and Protein Drug Manufacturing
Introduction
Satoshi Tomita is a prominent inventor based in Tokyo, Japan. He has made significant contributions to the fields of virus inactivation and protein drug manufacturing. With a total of 2 patents, his work has the potential to impact medical and pharmaceutical industries.
Latest Patents
Tomita's latest patents include a virus inactivation method and a method for manufacturing protein drugs. The virus inactivation method involves irradiating a solution containing an artificially expressed antibody or antibody fragment with ultraviolet rays in the presence of a radical scavenger. This innovative approach ensures that only 5% or less of the antibody or antibody fragment aggregates. The ultraviolet rays used have a wavelength ranging from 200 nm to 315 nm, with an irradiation amount of 300 mJ/cm or more and an irradiation time of 3 minutes or less. Additionally, the concentration of the radical scavenger in the solution is maintained at 0.03 mM or more.
Another notable patent is a sterile connector designed for efficient engagement between two tubes. This connector includes first and second connectors of the same shape, each featuring a body portion with a joining surface, an engaging member, and a fitting portion for tube connection. The design ensures that when the connectors are engaged, the end faces of the tubes are compressed against each other, enhancing sterility and functionality.
Career Highlights
Throughout his career, Satoshi Tomita has worked with notable organizations, including Able Corporation and Kobe University. His experience in these institutions has allowed him to develop and refine his innovative ideas, contributing to advancements in his field.
Collaborations
Tomita has collaborated with several professionals, including Kazuhisa Uchida and Shutaro Ishikawa. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.
Conclusion
Satoshi Tomita's contributions to virus inactivation and protein drug manufacturing highlight his role as a significant inventor in the medical field. His innovative patents and collaborations demonstrate his commitment to advancing technology for better health solutions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile